rohit890's blog

The global 3D bioprinting market is projected to witness significant expansion over the next decade, fueled by rapid advancements in regenerative medicine, biofabrication technologies, and personalized healthcare applications. The market is expected to grow from approximately USD 2.9 billion in 2026 to nearly USD 9.5 billion by 2036, registering a CAGR of 12.7% during the forecast period, according to the latest analysis by Future Market Insights (FMI).

The global sphingolipids market is projected to witness steady expansion over the next decade, driven by increasing research activity in lipidomics, rising therapeutic applications, and growing demand for high-purity bioactive lipids across pharmaceutical and biotechnology industries. The market is expected to grow from approximately USD 744.8 million in 2026 to nearly USD 1,224.8 million by 2036, registering a CAGR of 5.1% during the forecast period, according to the latest analysis by Future Market Insights (FMI).

The global biosimilar monoclonal antibody comparability test platforms market is expected to witness substantial growth between 2026 and 2036, fueled by the rapid expansion of biosimilar drug pipelines, increasing regulatory scrutiny, and growing investments in analytical similarity testing. According to the latest analysis by Future Market Insights (FMI), the market is being shaped by the rising need for high-precision characterization platforms capable of ensuring biosimilar safety, efficacy, purity, and structural consistency throughout the development lifecycle.